Microinjection into single cells in intact tissue allows the delivery of membrane-impermeant molecules such as nucleic acids and proteins is a powerful technique to study and manipulate the behavior of these cells and, if applicable, their progeny. However, a high level of skill is required to perform such microinjection and is a low-throughput and low-yield process. The automation of microinjection into cells in intact tissue would empower an increasing number of researchers to perform these challenging experiments and could potentially open up new avenues of experimentation. We have developed the 'Autoinjector', a robot that utilizes images acquired from a microscope to guide a microinjection needle into tissue to deliver femtoliter volumes of liquids into single cells. The robotic operation enables microinjection of hundreds of cells within a single organotypic slice, resulting in an overall yield that is an order of magnitude greater than manual microinjection. We validated the performance of the Autoinjector by microinjecting both apical progenitors (APs) and newborn neurons in the embryonic mouse telencephalon, APs in the embryonic mouse hindbrain, and neurons in fetal human brain tissue. We demonstrate the capability of the Autoinjector to deliver exogenous mRNA into APs. Further, we used the Autoinjector to systematically study gap-junctional communication between neural progenitors in the embryonic mouse telencephalon and found that apical contact is a characteristic feature of the cells that are part of a gap junction-coupled cell cluster. The throughput and versatility of the Autoinjector will not only render microinjection a broadly accessible high-performance cell manipulation technique but will also provide a powerful new platform for bioengineering and biotechnology for performing single-cell analyses in intact tissue.
INTRODUCTION
Microinjection into cells, in which a glass micropipette is briefly inserted into the cytoplasm or nucleus of a cell to introduce femtoliters of reagents, notably membrane-impermeant ones, is an important tool to manipulate and track single cells and, if applicable, their progeny [1] [2] [3] [4] . Recently, microinjection has been adapted to target single neural stem cells in intact developing brain tissue, where it offers several unique advantages 5, 6 . First, thanks to its excellent single cell resolution, microinjection of fluorescent dyes allows correlating single cell behavior as observed upon live imaging with tissue morphogenesis. Second, microinjection provides flexibility with regards to the chemical composition and complexity of the solution delivered into the cells. For example, pools of RNAs, or even an entire transcriptome, can be delivered into a cell, which allows for the combinatorial analysis of genes affecting brain development [6] [7] [8] [9] . Moreover, unlike electroporation, microinjection enables the delivery of both charged and non-charged molecules.
Finally, recent work has shown that microinjection can target neural stem cells from multiple species 5 and can be used for CRISPR/Cas9-mediated disruption of gene expression 7 .
Despite the advantages it offers, microinjection suffers of several limitations: it is a low-throughput and low-yield process and it requires a high level of skill and significant practice to master. Ideally, the stereotyped operation of precisely steering the microinjection pipette to cells while visualizing the pipette and tissue under microscope guidance can be implemented by a robotic system, so that sources of variability such as the depth of microinjection, the spacing between injections, and the volume of solution delivered to the cells can be precisely controlled. Such a robot would greatly increase throughput and yield of microinjection in tissue, opening this technology to a greater user base within neuroscience, developmental biology, cell biology and biophysics.
Here we report the development of an image-guided microinjection robot, the 'Autoinjector', that utilizes images acquired from a microscope to guide the microinjection needle into single cells in tissue at controlled pressure with micrometer-scale precision. This process can be repeated to target hundreds of cells, thereby increasing the rate and success of microinjection by an order of magnitude as compared with manual operation. The Autoinjector allowed us to target neural stem cells and follow their lineage progression in culture over time. The Autoinjector was also used to study the cell-to-cell communication in the developing mouse telencephalon. We focused our attention on gap-junctional coupling in neural stem and progenitor cells and found that coupled clusters contain both apical and basal progenitors, the two main classes of stem and progenitor cells in the mouse developing brain. Finally, we made use of the micrometer-scale precision and the flexibility of the robot by targeting single newborn neurons in organotypic slices from the mouse and human developing brain, a result never achieved before. The Autoinjector can be implemented on any standard microscope setup and will be a valuable resource for developmental neurobiologists to study brain development. Not limited to the developmental biology field, the Autoinjector will enable the quantitative analysis of single cell behavior in intact tissue in developmental biology, cell biology and biophysics.
RESULTS

The Autoinjector -a robot for image-guided microinjection into single cells in intact tissue
A typical microinjection experiment involves a user guiding the injection micropipette to the surface of the tissue, inserting the pipette tip into the tissue while the micropipette is held under positive pressure to perform the injection, and withdrawing the micropipette back within a brief period. The depth of tissue penetration and time the micropipette stays inserted inside the cell affect the efficacy of microinjection. Both these parameters are highly dependent on individual experimenter's skill and experience and are thus prone to inconsistencies, thereby leading to low yield 5, 6 . Lastly, the procedure is extremely tedious to perform. All these hurdles prevent users from injecting a large number of cells, making microinjection into cells in tissue challenging to be used as a robust tool to track and manipulate cells.
We built a robot, the 'Autoinjector', which can precisely control the position of the injection micropipette using microscope image guidance ( Fig. 1) . The Autoinjector requires relatively simple modifications to a conventional microinjection station. The injection micropipette is attached to a micropipette holder with a pressure inlet which is mounted on a manipulator for programmatic three-axis position control (Fig. 1A) . The manipulator is integrated into an inverted microscope ( Fig. 1A, C) , and the pressure inlet is connected to a custom pressure regulator for precise pressure control ( Fig. 1B, C) . Images acquired from the microscope camera are used by an algorithm to guide the injection micropipette to precise locations in the microscope field of view (FOV) (Fig. 1C, 2B ).
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A video illustrating the operation of the Autoinjector using organotypic slice cultures of embryonic day 16.5 (E16.5) mouse telencephalon is shown in Supplementary Video 1. First the magnification of the microscope objective is set by the user in the graphic user interface (GUI, Supplementary Fig. 1) . The injection micropipette is brought into the microscope FOV and imaged along with the tissue (Figure 2B top, Fig. 2C .i). This is followed by a calibration step, where displacement of the injection micropipette in three dimensions is projected onto the corresponding displacement in the two-dimensional microscope image (Supplementary Fig. 2A , Supplementary Note 1). Once the calibration step is completed, the Autoinjector can guide the injection micropipette to specific locations in the FOV using the micromanipulator, similar to previous algorithms 10, 11 . The user then draws a line along the desired path of microinjection on the microscope image using the graphical user interface (GUI) ( Fig. 2B bottom, Fig 2C. iii). This is followed by specifying the starting point of the injection micropipette by clicking the tip of the microinjection pipette in the GUI (Fig. 2B, bottom, Fig. 2C .iv). The algorithm then computes a trajectory (Supplementary Note 2) based on the depth into tissue the injection micropipette penetrates for each microinjection attempt, the distance the micropipette is pulled out of the tissue after an injection attempt, and the spacing between subsequent microinjection attempts. Each of these parameters can be independently specified by the user in the GUI (Supplementary Figs 1 and 2, Supplementary Note 2). Next, the Autoinjector positions the tip of the injection micropipette at the surface of the tissue, inserts the injection micropipette into the tissue to perform a microinjection, retracts the injection micropipette, and positions the injection micropipette at the next location along the path ( Fig. 2C.v, Supplementary Video 1) . This process is repeated until microinjections are completed along the entire path annotated by the user. A constant userdefined pressure is applied to the injection micropipette using the pressure controller throughout this process.
Prior to microinjection experiments, we investigated the Autoinjector's ability to target locations specified by the user in the microscope FOV. The experimenter annotates the tip of the microinjection pipette at various steps during calibration. Differences in individual perception of the micropipette tip may lead to systematic errors in positioning the pipette after calibration. To test for these effects, three experimenters with no prior experience using the Autoinjector performed calibration (Supplementary note 3) . The angle between the camera FOV reference axes and the micropipette reference axes, a key parameter used in performing the transformation between the two coordinate systems (Supplementary Note 1), was not significantly different when calibration was performed by either experimenter. To quantify the spatial error of the Autoinjector, pipettes were calibrated by the expert experimenter and commanded to 8 locations spread across 75% of the FOV which represents the area where the targeted tissue is located.
The error in image-guided positioning of the pipette was 0.211 ± 0.182 µm along the x axis and 0.345 ± 0.415 µm along the y axis of the manipulator (n = 8 locations, 5 measurements per location). This error in spatial positioning is much smaller than dimensions of the trajectories (10's to 100's of µm) used and was thus sufficient for image-guided targeting of single cells across the samples.
Optimizing automated microinjection
Having established that the injection micropipette could be guided to locations in the microscope FOV with micrometer scale precision, we attempted injection of fluorescent dye into apical progenitors (APs) in organotypic slices of the E14.5 mouse telencephalon and optimized the parameters for automated microinjection ( Fig. 3, Supplementary Video 2) . APs are important cells for the generation of mature neurons in the neocortex and are key to understanding how higher level cognitive functions evolved in mammals [12] [13] [14] [15] . Injecting APs with dye and tracking their progeny provides a good model for studying stem cell biology and cell fate specification in tissue [5] [6] [7] . The apical plasma membrane of APs faces the ventricle (Fig 2A. ) and their nuclei are found at distances ranging from 5 to 150 µm from the apical plasma membrane depending on the phase of cell cycle [14] [15] [16] . During microinjection, we approached APs from the ventricular surface. An ideal microinjection attempt targets the apical process of the APs injecting roughly 10% of the cytosolic volume 6 . Experimenters modulate the internal pressure of the injection micropipette between 75 to 125 mbar pressure during microinjection 5, 6 . This internal pressure is a key determinant of the injection volume. We used this range as a heuristic starting point and investigated how the internal pressure of the injection micropipette affected microinjection yield ( Fig. 3A. Fig. 3B.) .
Microinjections were performed at a depth of 10 µm from the ventricular surface. Microinjections performed at 75 mBar resulted in 35% of cells successfully injected (n = 314 attempts total, 2 slices). When performed at 100 mBar 35% of cells were successfully injected (n = 185 attempts total, 2 slices), whereas when microinjections performed at 125 mBar resulted in 8% of cells successfully injected (n = 287 attempts total, 2 slices). Given that there was no significant difference between the microinjection efficiency obtained when applying an internal pressure set at 75 mBar vs 100 mBar, we decided to use a pressure of 75 mBar pressure to minimize the stress applied to the cells and to the tissue during microinjection.
We next assessed how the depth to which the pipette penetrates tissue affects microinjection yield. The Autoinjector was programmed to axially penetrate to depths of 10, 15 and 25 μm from the assigned ventricular surface for microinjection ( Fig. 3B) with the internal pressure of the micropipette set to 75 mBar. With a 45 degree approach angle relative to the normal to the tissue surface, this translated to 5, 11 and 18 μm depths from the assigned ventricular surface. This range of depths accounted for variation in cell locations and potential deformations of the ventricular surface during microinjection. Microinjections performed at depths of 10 µm resulted in 68% of cells successfully injected (n = 163 microinjection attempts, 2 slices). Microinjections performed at depths of 15 µm resulted in 22% of cells successfully injected (n = 170 microinjection attempts, 2 slices). Microinjections performed at depths of 25 µm resulted in 11% of cells successfully injected (n = 169 microinjection attempts, 2 slices). For the subsequent experiments we used an injection depth of 10 µm for injecting APs unless otherwise stated. Robotic control of pressure and position thus allowed us to systematically explore parameters affecting microinjection yield.
Comparison of manual and automated microinjection
We next compared the performance of the Autoinjector to manual microinjections performed by a novice experimenter (no prior microinjection experience) and an experienced experimenter (5 years of microinjection experience, Fig. 3C-E) . The Autoinjector was operated by a user with no prior microinjection experience. The optimized depth and pressure parameters derived above were used in these experiments (pressure = 75 mbar, depth = 10 μm). A successful microinjection was indicated by co-localization of the microinjected dye, Dx3-Alexa488, and DAPI, in slices fixed immediately after the experiment. We found that a novice experimenter performing manual microinjection had a success of 6.67 ± 4.71 % with an injection rate of 12.10 ± 2.40 attempts/minute (n = 120 attempts, 3 slices). This corresponds to a successful microinjection rate of 0.83 ± 0.63 injections per minute. An experienced experimenter performing manual microinjection had a success of 19.58 ± 2.91 % with an injection rate of 21.25 ± 3.29 attempts/minute (n = 70 attempts, 2 slices). This corresponds to a successful microinjection rate of 4.25 ± 1.26 injections per minute. A novice user performing microinjection using the Autoinjector had a success of 43.73 ± 9.11 % with an injection rate of 35.92 ± 2.12 attempts/minute (n = 864 attempts, 4 slices). This corresponds to a successful microinjection rate of 15.52 ± 2.48 injections per minute. Thus, a novice experimenter using the Autoinjector achieved a 19-fold increase in injection rate relative to a novice experimenter performing manual microinjections, and a 5-fold increase in injection rate relative to an experienced experimenter performing manual microinjections. The increase in injection rate enabled by the Autoinjector represents a significant improvement in yield. Furthermore, the higher throughput could be advantageous for performing time-sensitive experiments which are otherwise not possible.
Autoinjector allows tracing cell fate transition and lineage progression of neural stem and progenitor cells in tissue
Microinjection is a useful tool to track neural stem and progenitor cells and their progeny in organotypic slice culture as individual cells can be labeled in a sparse and spatially defined fashion 17 . We used the Autoinjector to inject APs along the ventricular surface and tracked the location, morphology, and cell identity of the injected cells and their progeny after 0, 24, and 48 hours in culture ( Fig. 4) . The injected cells and their progeny were scored based on the distance of the cell body from the ventricular surface and based on the layer in which they reside (ventricular zone (VZ), subventricular zone (SVZ), or cortical plate (CP), Fig. 2A.) . Cell identity was determined by assessing the positivity for T-box brain protein 2 (Tbr2), a transcription factor characteristically expressed by basal intermediate progenitors (bIPs) in mouse 18 , and for the neuron-specific class III β-tubulin (TuJ1) 19 . At time zero, 100% of the injected cells (n =147 cells total) were in the VZ (Fig. 4D.) and were bearing an apical attachment (not shown). After 24 h in culture, 31% of the progeny of injected cells (n = 151 cells total) were in the VZ, while 59% were found in the SVZ, and 10% in the CP. After 48 h in culture, 23% of the injected cells (n = 26 cells total) were in the VZ, 31% in the SVZ, and 47% in the CP. The redistribution of the injected cells and their progeny to a more basal compartment was paralleled by an increase in their distance from the apical surface ( Fig. 4E ) and by a change in cell identity ( Fig. 4F and G) . At 0 h, the cells targeted by microinjection were all TuJ1 negative (n = 13 cells total). A fraction of the microinjected cells was Tbr2 positive (10.38%; n = 77 cells total), consistent with previous results 5 and with the notion that a newborn basal progenitor (BP) retains an apical contact when it is generated 20 and can be therefore targeted by microinjection. After 24 h in culture, 32% of cells were Tbr2-positive and 33% were TuJ1-positive (n = 92 cells total), indicating a shift toward a more basal cell identity.
After 48h in culture, 50% of cells were Tbr2-positive and 66% were TuJ1-positive (n = 18 cells total), indicating the continuous progression of cells toward BP and neuronal cell identity. Thus, the assessment of localization, distance and cell identity at 0, 24 and 48 h after microinjection suggests that the Autoinjector does not interfere with the normal ability of the APs to generate downstream progeny, represented by BPs and neurons. Taken together, the data shown here demonstrate that Autoinjector allows tracing cell fate transition and lineage progression of neural stem and progenitor cells in tissue.
Delivery of exogenous mRNA via microinjection
Genetic manipulation of neural progenitors is an invaluable tool to investigate the genetic basis of neocortex development and evolution 9, 15, 21, 22 . Injection of mRNA of genes of interest into cells allows the effects of these genes on neocortex development to be quantified 5, 6, 8, 9 . We used the Autoinjector to inject the mRNA for red fluorescent protein (RFP) into cells along with an injection dye and observed the ability of the injected cells and their progeny to express the RFP after 24 hours in organotypic slice culture. Of the cells that were injected, 47% expressed RFP after 24 h in culture (n = 17 cells in total) as indicated by the co-localization of the injection dye and the presence of RFP fluorescence (Figs 4H, 4I) . The yield of RFP translation with the Autoinjector represents an improvement compared with previously reported translation yield (≈20%) using manual microinjection 17 .
Autoinjector allows a quantitative dissection of cell-to-cell-communication in the developing brain
We used the Autoinjector to gain insight into cell-to-cell communication in the developing brain, focusing on gap junction communication. Gap junctions are intercellular channels that allow direct diffusion of ions and small molecules between adjoining cells in intact tissue and are thought to play important roles in development including neuronal differentiation, migration, and circuit organization [23] [24] [25] [26] . We used the Autoinjector to microinject a combination of gap junction permeable fluorescent dye (Alexa-488) and gap junction impermeable fluorescent dye (Dx-3000-Alexa-555) into APs. To identify unique clusters of coupled cells, we programmed the Autoinjector to perform injections on cells separated by 30 µm. The slices were fixed immediately after microinjection to make sure we were detecting clusters of coupled cells and not clusters of daughter cells forming as a consequence of lineage progression. This experimental paradigm allowed us to quantitatively determine (i) how many neural stem cells are coupled via gap junctions, (ii) the size and distribution of coupled clusters and (iii) the contribution of different neural stem cell types to the coupled clusters ( Fig. 5) .
We found that at mid-neurogenesis in the mouse developing brain one third of the targeted cells are part of a coupled cluster (Fig 5, A-D) . The cluster size is variable and ranged from 2 to 8 cells ( Fig. 5E) . The majority of clusters are two-cell clusters (Fig 5E) . Of note, in all two-cell clusters the junction-impermeable dye (Dx-3000-Alexa-555) labels only one cell (Supplementary Fig. 3) , ruling out the possibility of a daughter cell pair connected by a midbody bridge and confirming that the two cells are coupled via gap junctions. Furthermore, coupled cells are confined to the VZ (Fig. 5F) and tend to occupy a more apical position compared non-coupled cells. This observation is consistent with the idea that coupling is cell-cycle dependent and that, at least in late neurogenesis, cells in S-phase are less likely to be part of a coupled cluster 26 .
To assess the identity of the coupled cells, we next stained the tissue for Tbr2, a marker for mouse BPs (Fig. 5K) . We found that only a minor proportion of coupled cells (9%) are Tbr2-positive (n = 13 46 cells total). If one considers the entire VZ, then >30% of the cells in the VZ are Tbr2positive 27, 28 . This discrepancy suggests that the coupled clusters contain a sub-population of Tbr2-positive cells. From a cell biological point of view, the VZ contains two sub-populations of Tbr2-positive cells: one that keeps an apical contact (non-delaminated) and one that lost it during delamination (delaminated) 20 . We checked for polarity cues in coupled cells and we found that the vast majority of cells (98% of cells) in coupled clusters have an apical process and therefore maintain an apical polarity cue (Fig. 5J) . These data suggest that the maintenance of the apical contact is a crucial factor influencing the ability of a Tbr2-positive cell to be part of a cluster. Taken together, these results demonstrate that the Autoinjector can be used to gain insight into the fine cell biology of neural stem cells in organotypic slices of the developing brain.
Targeting newborn neurons in the developing mouse and human telencephalon
Finally, we wanted to determine if automated microinjection could be applied in a generalized manner to different cell types in the developing mouse brain, and if it could be performed in tissues from other species. We first tested the ability of the Autoinjector to target APs in the hindbrain, the tissue where manual injection was originally developed 17 . As shown in Supplementary Fig.   4 , the Autoinjector successfully targets hindbrain APs, highlighting their morphology. We then used the Autoinjector to microinject newborn neurons in organotypic slices. Neurons are extremely challenging to target with manual microinjection because of their distance from the basal surface and the topology of the tissue (Fig. 6A) . In order to target newborn neurons, the Autoinjector approached the tissue slice from the basal surface and was programmed to target cells at a variable depth (10 to 35 µm) from the basal surface. The microinjections were spaced 30 µm apart to better visualize neural morphology (Fig. 6B) . As shown in Figs. 6C and D, neurons in different layers, corresponding to different neuronal subtypes, were targeted (n = 12 cells total).
The subtypes targeted were Reelin-negative newborn pyramidal neurons (83% of cells, Fig. 6C 14 top row), and Reelin-positive, Cajal-Retzius neurons (17% of cells, Fig. 6C, bottom row) . These data demonstrate that the Autoinjector can target two neuronal subtypes present in the developing mouse telencephalon.
We then used the Autoinjector to target the developing human brain. The use of human tissue provides an invaluable tool to study neocortex development and evolution 12, 15, [29] [30] [31] [32] [33] [34] [35] . We first tested if the Autoinjector could target APs in organotypic slices of fetal stage 12 weeks post conception (12 wpc) human telencephalon. We found that the Autoinjector could successfully target APs from the apical surface of a human organotypic slice (Supplementary Fig. 5) . Additionally, the Autoinjector targeted human neurons and revealed their morphology ( Fig. 6E-F) . Thus, the Autoinjector can be used to target the same cell types in mouse and human organotypic slices.
These data strongly indicate that the Autoinjector can potentially be adapted and optimized for other organisms to study development and evolution at the cellular level.
DISCUSSION
Here we report the development of the Autoinjector, an image-guided robotic device that can perform microinjection into single cells in tissue in an automated fashion.
A central goal in biology is understanding how single cell behavior impacts on tissue development and function. In the developing brain, a dynamic and complex tissue, neural stem cells divide and give rise to neurons. Several techniques have been developed to label, manipulate and follow single neural stem cells in the developing brains of different species 6, 33, [36] [37] [38] [39] [40] [41] [42] [43] . All techniques and systems face a trade-off between (i) the control of the composition of solution that is delivered to the cells, (ii) the number of cells that can be targeted, (iii) the time and economical effort necessary to perform it, (iv) the ability to provide single cell resolution, and (v) the physiological relevance of the model system. Here we show that the Autonjector can address and overcome all these major challenges and limitations.
Firstly, the automated microinjection into single cells provides great control over the solution delivered into the cells, both in terms of its chemical composition and its complexity, as shown by the injection of the fluorescent dye(s) (either alone or in combination) and mRNAs.
The Autoinjector enabled us to inject hundreds of APs across 1 mm of the apical surface of an organotypic slice of the mouse telencephalon, a feat previously too challenging to achieve with manual microinjection. The superior performance of the Autoinjector is linked to an increased success rate of microinjection and decreased time of the injection procedure relative to manual systems, resulting in a 5-fold to 19-fold increase in performance compared with the manual injection platform. Of note, the Autoinjector is fully open-source, and can be implemented on any standard microscope setup with minor modifications and without significant additional costs. A complete parts list, the software package and instructions for assembling the hardware have been made available for the reader (See Data and Code Availability).
The excellent single cell resolution provided by the autoinjector allowed us to follow the injected cells and their progeny up to 24 and 48 h in organotypic slice culture and to assess their morphology, location and identity. The Autoinjector will allow in the future to systematically study lineage progression by combining morphological assessment of single cell behavior with the respective transcriptome profiling. This would pave the way to a better understanding of the genetic logic of cell fate specification during development and evolution.
Furthermore, we used the excellent single cell resolution achieved with the Autoinjector to gain insight into the cell biology of neural stem cells, focusing on gap junction communication between APs in E14.5 organotypic slices of the mouse telencephalon. Gap junctions are channels allowing the exchange of small molecules across populations of cells during development 25, 44 . Although gap junctional coupling has been studied in neural progenitors using whole cell patch clamping 26, 44 , to our knowledge the stem cell type specificity of coupling has not been addressed before. We used the Autoinjector to address this point and, consistent with previous reports 26 , found that coupled clusters are formed preferentially by cells that reside in the ventricular zone.
In addition, we could quantitatively assess that (i) coupled clusters have a variable size and 30% of clusters are two-cells clusters, (ii) the two-cell clusters are not daughter cell clusters, (iii) coupled clusters include Tbr2-negative and -positive cells, suggesting the existence of clusters containing both APs (Tbr2 negative) and BPs (Tbr2 positive), and (iv) the apical attachment is a key factor influencing the ability of a cell to be part of a cluster. The ability of the Autoinjector to be easily adapted to different tissues and species allows for a systematic analysis of junctional coupling in different areas of the neural tube (dorsal vs ventral telencephalon, hindbrain) and in species with different brain size.
Finally, we show that the Autoinjector can be applied in generalized manner to target other cell types and species of relevance. The precise spatial control of the Autoinjector allowed us to inject pyramidal neurons in the mouse developing telencephalon by consistently performing microinjections at a depth of 30 µm from the basal surface. By simply changing the depth of injection to 10 µm, the Autoinjector was able to target Cajal-Retzius neurons in both the mouse and human developing brain, illustrating the flexibility of our robotic device. The Autoinjector can therefore be used to manipulate and study different types of neurons in the developing brain of different species. We can anticipate that the autoinjector will allow the dissection of the molecular mechanisms governing synapse formation, a crucial event involved in learning and memory [45] [46] [47] and in developmental disorders such as Autism Spectrum Disorder (ASD) and mental retardation 48, 49 . Additionally, by simply changing the developmental stage at which the injection is performed, one would be able to target any neuronal type/layer. Furthermore, other cell types may be targeted in different tissues or/and at different depths within the same tissue, provided (i) a good anatomical and histological knowledge about the tissue organization and (ii) accessibility of the cells via the tissue surface(s). Future work could focus on expanding the Autoinjector platform to inject other developmental model organisms (chick, zebrafish, Drosophila, C. elegans) and even non-model organisms for which transgenesis is not available.
In conclusion, we demonstrated that the combination of robotic automation, real-time image acquisition and analysis leads to a significant increase in the efficiency of a difficult laboratory technique, such as microinjection into single cells in tissue. Robotic systems have enabled the automation of difficult laboratory techniques that require precise micromanipulation such as in vivo patch clamping of single [50] [51] [52] as well as multiple neurons in vivo 53 . Additionally, previous work relied on camera images to guide automated patch clamping systems to specific locations in tissue 11, 54 . These applications resulted in significant improvement in the success of patch clamping and enabled neuroscientists to perform complex experiments previously limited by technical difficulties. To our knowledge, this is the first attempt to automatically perform microinjection into single neural stem cells and newborn neurons in intact brain tissue. The principle we developed of using visual cues to target specific locations can be applied to any tissue with an a priori knowledge of the location of cells. Based on the high efficiency we achieved in injecting APs and newborn neurons both in the mouse and in the human telencephalon, we predict that this process will be further implemented in applications where microinjection was previously not considered possible.
MATERIALS AND METHODS
Microinjection Hardware
We designed the Autoinjector (Fig. 1) by modifying a standard microinjection system described previously 5 . The Autoinjector hardware is composed of a pipette mounted in a pipette holder (64-2354 MP-s12u, Warner Instruments, LLC) attached to a three-axis manipulator (three-axis uMP, Sensapex Inc) for precise position control of the injection micropipette. A microscope camera (ORCA, Hamamatsu Photonics) was used for visualizing and guiding the microinjection, and a custom pressure regulation system adapted from previous work 55 was built for programmatic control of injection pressure. The pressure regulation system consisted of manual pressure regulator (0 -60 PSI 41795K3, McMaster-Carr) that downregulated pressure from standard house pressure (~2400 mBar) to 340 mBar. The output from the manual pressure regulator was routed to an electronic pressure regulator (990-005101-002, Parker Hannifin) that allowed fine tuning of the final pressure going to the injection micropipette (0 -250 mbar) using the control software. A solenoid valve (LHDA0533215H-A, Lee Company) was then used to digitally switch the pressure output to the injection micropipette. A microcontroller (Arduino Due, Arduino) was used to control electronic pressure regulation via a 0 -5 V analog voltage signal and the solenoid via a digital transistor transistor logic (TTL) signal (Fig. 1A. -Fig. 1C.) . The computer controlled the three-axis manipulator via an ethernet connection and controlled the camera and microcontroller via Universal serial bus (USB) connections. All hardware was controlled by custom software as described in the next section.
Microinjection Software and Operation
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All software was written in python (Python Software Foundation) and Arduino (Arduino) and is available for download with instructions at https://github.com/bsbrl/autoinjector. We developed a graphical user interface (GUI) in python to operate the microinjection platform ( Supplementary   Fig. 1.) . The GUI allowed the user to image the tissue and micropipette, and to customize the trajectory of microinjection.
Mouse Slice Preparation
All animal studies were conducted in accordance with German animal welfare legislation, and the necessary licenses were obtained from the regional Ethical Commission for Animal Experimentation of Dresden, Germany (Tierversuchskommission, Landesdirektion Dresden).
Organotypic slices were prepared from E14.5 or E16.5 mouse embryonic telencephalon or hindbrain as previously described 17 . C57BL/6 mouse embryos were used (Janvier Labs). Briefly, the mouse telencephalon was dissected at room temperature in Tyrode's solution. After the removal of meninges, the tissue was embedded 3% low-melting agarose (Agarose Wilde Range, A2790, Sigma-Aldrich) in PBS at 37°C. After solidification of the agarose upon cooling to room temperature, 300-400 µm coronal slices were cut using a vibratome (Leica VT1000S, Leica). The slices were transferred to 3.5-cm dishes containing 37°C-warm slice-culture medium (SCM:
Neurobasal medium (Thermo Fisher Scientific), 10% rat serum (Charles River Japan), 2 mM Lglutamine (Thermo Fisher Scientific), Penstrep (Thermo Fisher Scientific), N2 supplement (17502048, Thermo Fisher Scientific), B27 supplement (17504044, Thermo Fisher Scientific), 10 mM Hepes-NaOH pH 7.3). Until the start of microinjection slices were kept for 5-10 min in a sliceculture incubator maintained at 37°C and gassed with a humidified atmosphere of 40% O 2 / 5% CO 2 / 55% N 2 (Air Liquide).
Human Slice Preparation
Human fetal brain tissue was obtained from the Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Carl Gustav Carus of the Technische Universität Dresden, with informed written maternal consent, followed by elective pregnancy termination. Research with human tissue was approved by the Ethical Review Committee of the Universitätsklinikum Carl Gustav Carus of the Technische Universität Dresden (reference number: EK100052004).
Immediately after termination of pregnancy, the tissue was placed on ice and transported to the lab. The sample was transferred to ice-cold Tyrode's solution, and tissue fragments of cerebral cortex were identified and dissected 56 . The tissue fragment suitable for microinjection was kept in SCM in a humidified and oxygenated bottle at 37°C for at least one hour to allow the tissue to recover. Organotypic slices were then cut by hand using a micro-knife. The thickness of the slices was variable and ranged between 300 and 500 µm. Slices were transferred to a 3.5-cm dish containing 37°C-warm SCM and kept in the slice culture incubator until the start of microinjection.
Micropipette preparation
Glass capillaries (1.2 mm O.D. x 0.94 mm I.D., Harvard Apparatus (BF-120-94-10) were pulled into micropipettes using a micropipette puller (P-97 Flaming Brown, Sutter instruments, Novato, CA).
Microinjection solution preparation
All the injection solutions were made up with RNase-free bi-distilled water. Solutions always contained a fluorescently labeled dye (Alexa-coupled Dextrans and/or Lucifer Yellow; Thermo Fisher Scientific, from 10 µg/µl stocks; (for the complete list of fluorescently labeled dyes used, see Supplementary Table 1 ) at 2-5 µg/µl to trace the microinjected cells and their progeny. For the mRNA injections, in vitro-transcribed (ivt) poly-A mRNA for RFP was prepared as previously described 17 using the T7 mMessage-mMachine Ultra kit (Thermo Fisher Scientific). Briefly, RFP ivt-RNA was dissolved in RNase-free bidistilled water at 1 µg/µl and snap-frozen as 1-2 µl aliquots. Before the start of microinjection RNA was heated to 90°C for 45 sec and cooled to 4°C before the addition of the Dextran-Alexa 488. For the coupling experiments, Dextran-Alexa555 was mixed with the Alexa488, whose molecular weight (MW: 884.91 Da), is below the reported cut-off of the gap junctional channels 57 . For the neuron injections, Dextran-A555 was mixed with Lucifer Yellow (LY), a low molecular weight fluorescent tracer allowing for a better visualization of the neuronal morphology 58 . All solutions for microinjection were centrifuged at 16,000g for 30 min at 4°C. The supernatant was collected, kept on ice, and used for microinjection. The injection solution was loaded into micropipettes and the micropipette was mounted onto the micropipette holder.
Microinjection
Immediately before the start of microinjection, brain slices were transferred to 3.5-cm dishes containing 37°C-warm CO 2 -independent microinjection medium (CIMM: DMEM-F12 (Sigma D2906) 2 mM L-glutamine, Penstrep, N2 and B27 supplements, 25 mM (final concentration)
Hepes-NaOH pH 7.3) and positioned on the microscope stage (Axiovert 200, Zeiss, Jena). The micropipette was brought into the field of view of the microscope close to the edge of the tissue using a 10x objective lens (Zeiss, Jena). To verify that the micropipette was not clogged, pressure was applied through the GUI, and the appearance of a fluorescent signal was checked. If no fluorescence was observed, the micropipette was changed and the positioning was repeated. If the micropipette was in optimal conditions (not clogged), the microinjection was carried out using a 20x objective lens (Zeiss, Jena) to allow for a better visualization of the procedure. Manual microinjections were performed as described previously 5 . Automated microinjection was performed as illustrated in Supplementary Video 1 and Supplementary Video 2.
Slice culture
Slices were prepared as previously described 17, 59 . The slices were immersed in collagen and transferred with ~200 μl of collagen solution into the 14-mm well of a 35-mm Glass Bottom Microwell Dish (MatTek). The dish was placed for 5 min on a heating block at 37 °C. This transfer was defined as t = 0 of slice-culture and was followed by 40 min in the slice-culture incubator to allow the collagen to solidify. The dish then received 2 ml of SCM, and slice culture was continued in the slice-culture incubator for the indicated times (24 or 48 h).
Tissue fixation, fluorescence staining and imaging
At the end of the slice culture the SCM was removed, the dish was rinsed twice with fresh PBS and the slices were fixed in 4% paraformaldehyde in 120 mM sodium phosphate buffer pH 7.4 at room temperature for 30 min followed by 4°C overnight. Slices were removed from the collagen matrix using forceps and extensively washed in PBS before re-embedding in 3% low-melting agarose (Carl Roth) in PBS. After agarose solidification, 50-µm vibratome sections (also referred as floating sections) were cut parallel to the original cutting plane. Floating sections were collected in a 24-multiwell and processed for immunofluorescence using standard procedures (for the complete list of primary and secondary antibodies used, see Supplementary Table 1 ). Floating 
Image Analysis
All images were analyzed using ImageJ 60 and FiJI 61 . The cell's contours were traced using the fluorescent microinjection dye. Cell contours were stored using the ROI (region of interest) manager and were used (i) to identify the nucleus (ii) to determine the presence of Tbr2, TuJ1 and/or Reelin expression.
For the distance calculation, we calculated the distance between the ventricular surface (defined as 0 µm) and the center of the nucleus (identified in the optical section corresponding to the largest nuclear area). The distance values were binned as follows: 0 to <20µm, 20 to <40µm, 40 to <60µm, 60 to <80µm, 80 to <100µm, 100 to <120µm, 120 to <140µm, 140 to <160µm and >160µm.
Statistical Analysis Methods
All values reported represent the mean and ± represents standard deviation from the mean calculated using Microsoft Excel. All statistical testing for significance was done using two-tailed Welch's Student's t-test using MATLAB®. A p-value less than 0.05 was considered significant with p < 0.05 denoted with *, p < 0.001 denoted with **, and p < 0.0001 denoted with ***. 
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